The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells

doi:10.1083/jcb.105.2.957

PeproTech: Your source for Cell Biology Research Reagents

This Article

	Full Text (PDF, 1165K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JCB
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Saksela, O.
	Articles by Rifkin, D. B.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Saksela, O.
	Articles by Rifkin, D. B.


Social Bookmarking

	What's this?

ARTICLES

The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells

O Saksela, D Moscatelli and DB Rifkin

Basic fibroblast growth factor (bFGF), a potent inducer of angiogenesis in vivo, stimulates the production of both urokinase- and tissue-type plasminogen activators (PAs) in cultured bovine capillary endothelial cells. The observed increase in proteolytic activity induced by bFGF was effectively diminished by picogram amounts of transforming growth factor beta (TGF beta), but could not be abolished by increasing the amount of TGF beta. However, the inhibition by TGF beta was greatly enhanced if the cells were pretreated with TGF beta before addition of bFGF. After prolonged incubation of cultures treated simultaneously with bFGF and TGF beta, the inhibitory effect of TGF beta diminished and the stimulatory effect of the added bFGF dominated as assayed by PA levels. TGF beta did not alter the receptor binding of labeled bFGF, nor did a 6-h pretreatment with TGF beta reduce the amount of bFGF bound. The major difference between the effects of bFGF and TGF beta was that while bFGF effectively enhanced PA activity expressed by the cells, TGF beta decreased the amounts of both cell-associated and secreted PA activity by decreasing enzyme production. Both bFGF and TGF beta increased the secretion of the endothelial-type plasminogen activator inhibitor.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Ferrari, G., Pintucci, G., Seghezzi, G., Hyman, K., Galloway, A. C., Mignatti, P. (2006). VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA 103: 17260-17265 [Abstract] [Full Text]
Ponda, M. P., Hostetter, T. H. (2006). Aldosterone Antagonism in Chronic Kidney Disease. CJASN 1: 668-677 [Full Text]
Otsuka, G., Agah, R., Frutkin, A. D., Wight, T. N., Dichek, D. A. (2006). Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1-Dependent Pathways. Arterioscler. Thromb. Vasc. Bio. 26: 737-743 [Abstract] [Full Text]
Leksa, V., Godar, S., Schiller, H. B., Fuertbauer, E., Muhammad, A., Slezakova, K., Horejsi, V., Steinlein, P., Weidle, U. H., Binder, B. R., Stockinger, H. (2005). TGF-{beta}-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. J. Cell Sci. 118: 4577-4586 [Abstract] [Full Text]
Corallini, A., Possati, L., Trabanelli, C., Giraudo, E., Rocchetti, R., Talevi, S., Caputo, A., Bussolino, F., Barbanti-Brodano, G. (2003). Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-{beta}1. Carcinogenesis 24: 1435-1444 [Abstract] [Full Text]
Eddy, A. A. (2002). Plasminogen activator inhibitor-1 and the kidney. Am. J. Physiol. Renal Physiol. 283: F209-F220 [Abstract] [Full Text]
Cao, W., Mattagajasingh, S. N., Xu, H., Kim, K., Fierlbeck, W., Deng, J., Lowenstein, C. J., Ballermann, B. J. (2002). TIMAP, a novel CAAX box protein regulated by TGF-beta 1 and expressed in endothelial cells. Am. J. Physiol. Cell Physiol. 283: C327-C337 [Abstract] [Full Text]
Sakai, M., Asayama, K., Otabe, H., Kohri, T., Shirahata, A. (2001). Low Tissue Plasminogen Activator Relative to Plasminogen Activator Inhibitor-1 as a Marker of Cardiac Complication in Children With Kawasaki Disease. CLIN APPL THROMB HEMOST 7: 214-218 [Abstract]
Mishima, K., Mazar, A. P., Gown, A., Skelly, M., Ji, X.-D., Wang, X.-D., Jones, T. R., Cavenee, W. K., Huang, H.-J. S. (2000). A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. Proc. Natl. Acad. Sci. USA 10.1073/pnas.150239497v1 [Abstract] [Full Text]
Ren, S., Shen, G. X. (2000). Impact of Antioxidants and HDL on Glycated LDL-Induced Generation of Fibrinolytic Regulators From Vascular Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 20: 1688-1693 [Abstract] [Full Text]
Cronauer, M. V., Stadlmann, S., Klocker, H., Abendstein, B., Eder, I. E., Rogatsch, H., Zeimet, A. G., Marth, C., Offner, F. A. (1999). Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells : Induction by Interleukin-1. Am. J. Pathol. 155: 1977-1984 [Abstract] [Full Text]
Tran, N. D., Correale, J., Schreiber, S. S., Fisher, M., Chan, P. H. (1999). Transforming Growth Factor-{beta} Mediates Astrocyte-Specific Regulation of Brain Endothelial Anticoagulant Factors � Editorial Comment. Stroke 30: 1671-1678 [Abstract] [Full Text]
Lee, H., Struman, I., Clapp, C., Martial, J., Weiner, R. I. (1998). Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression. Endocrinology 139: 3696-3703 [Abstract] [Full Text]
Christ, G., Hufnagl, P., Kaun, C., Mundigler, G., Laufer, G., Huber, K., Wojta, J., Binder, B. R. (1997). Antifibrinolytic Properties of the Vascular Wall: Dependence on the History of Smooth Muscle Cell Doublings In Vitro and In Vivo. Arterioscler. Thromb. Vasc. Bio. 17: 723-730 [Abstract] [Full Text]
Hardy, M. M., Feder, J., Wolfe, R. A., Bu, G. (1997). Low Density Lipoprotein Receptor-related Protein Modulates the Expression of Tissue-type Plasminogen Activator in Human Colon Fibroblasts. J. Biol. Chem. 272: 6812-6817 [Abstract] [Full Text]
Mandriota, S., Pepper, M. (1997). Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. J. Cell Sci. 110: 2293-2302 [Abstract]
Roghani, M., Mohammadi, M., Schlessinger, J., Moscatelli, D. (1996). Induction of Urokinase-type Plasminogen Activator by Fibroblast Growth Factor (FGF)-2 Is Dependent on Expression of FGF Receptors and Does Not Require Activation of Phospholipase Cgamma 1. J. Biol. Chem. 271: 31154-31159 [Abstract] [Full Text]
Dinbergs, I. D., Brown, L., Edelman, E. R. (1996). Cellular Response to Transforming Growth Factor-beta 1 and Basic Fibroblast Growth Factor Depends on Release Kinetics and Extracellular Matrix Interactions. J. Biol. Chem. 271: 29822-29829 [Abstract] [Full Text]
Dong, G., Schulick, A. H., DeYoung, M. B., Dichek, D. A. (1996). Identification of a cis-Acting Sequence in the Human Plasminogen Activator Inhibitor Type-1 Gene That Mediates Transforming Growth Factor-beta 1 Responsiveness in Endothelium in Vivo. J. Biol. Chem. 271: 29969-29977 [Abstract] [Full Text]
Schaper, W., Ito, W. D. (1996). Molecular Mechanisms of Coronary Collateral Vessel Growth. Circ. Res. 79: 911-919 [Full Text]
Wang, W., Chen, H. J., Giedd, K. N., Schwartz, A., Cannon, P. J., Rabbani, L. E. (1995). T-Cell Lymphokines, Interleukin-4 and Gamma Interferon, Modulate the Induction of Vascular Smooth Muscle Cell Tissue Plasminogen Activator and Migration by Serum and Platelet-Derived Growth Factor. Circ. Res. 77: 1095-1106 [Abstract] [Full Text]
Mandriota, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., Pepper, M. S. (1995). Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells. J. Biol. Chem. 270: 9709-9716 [Abstract] [Full Text]
Frenz, D., Liu, W, Williams, J., Hatcher, V, Galinovic-Schwartz, V, Flanders, K., Van de Water, T. (1994). Induction of chondrogenesis: requirement for synergistic interaction of basic fibroblast growth factor and transforming growth factor-beta. Development 120: 415-424 [Abstract]
Montesano, R, Pepper, M., Orci, L (1993). Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts. J. Cell Sci. 105: 1013-1024 [Abstract]
Brenner, C A, Adler, R R, Rappolee, D A, Pedersen, R A, Werb, Z (1989). Genes for extracellular-matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development.. Genes Dev. 3: 848-859 [Abstract]
Pucci, M., Fibbi, G., Magnelli, L., Del Rosso, M. (2001). Regulation of Urokinase/Urokinase Receptor Interaction by Heparin-like Glycosaminoglycans. J. Biol. Chem. 276: 4756-4765 [Abstract] [Full Text]
Mishima, K., Mazar, A. P., Gown, A., Skelly, M., Ji, X.-D., Wang, X.-D., Jones, T. R., Cavenee, W. K., Huang, H.-J. S. (2000). A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin. Proc. Natl. Acad. Sci. USA 97: 8484-8489 [Abstract] [Full Text]